When non-surgical options for knee osteoarthritis are discussed, some patients hear about:
PRP injections
or
platelet-rich plasma therapy.
This often generates strong reactions.
Some patients see PRP as a modern regenerative solution.
Others assume it is expensive hype.
Common questions include:
- Does PRP work?
- Does it regrow cartilage?
- Is it better than steroid injections?
- Is it evidence-based?
- Is it suitable for everyone?
These are reasonable questions.
PRP remains one of the more debated interventions in knee osteoarthritis care.
Understanding what it is—and what realistic expectations look like—helps patients make more informed decisions.
What Is PRP?
PRP stands for platelet-rich plasma.
The general concept involves:
- taking a sample of the patient’s blood
- processing it
- concentrating platelet-containing components
- injecting selected material back into the treatment area
The rationale is based on the biological activity of platelet-associated growth factors and signalling molecules.
Important clarification:
PRP is not the same as stem cell therapy.
Why Is PRP Discussed In Osteoarthritis?
The idea is often framed around biological modulation rather than simple symptom masking.
Potential intended discussions may involve:
- symptom management
- inflammatory environment modulation
- biological signalling effects
- selected non-surgical management pathways
But this does not mean PRP has been proven to regrow an arthritic knee.
That is an important distinction.
Does PRP Regrow Cartilage?
This is one of the biggest misconceptions.
Patients often hear regenerative language and assume structural reversal.
Current evidence does not support simplistic claims that PRP predictably regrows clinically meaningful cartilage in established knee osteoarthritis.
That does not automatically mean PRP has no role.
It means expectations should remain realistic.
What Does The Evidence Say?
Evidence is mixed.
Some studies suggest symptom improvement in selected patients.
But interpretation varies depending on:
- PRP preparation method
- study quality
- injection protocol differences
- patient selection
- comparator interventions
- osteoarthritis severity
The American Academy of Orthopaedic Surgeons (AAOS) notes that evidence for PRP in knee osteoarthritis remains evolving, with limitations in consistency and interpretation.
This is not the same as saying PRP is definitively ineffective.
It means certainty remains limited.
Why PRP Research Is Difficult To Compare
A major challenge:
“PRP” is not one standardised intervention.
Differences may include:
- concentration methods
- leukocyte content
- preparation protocols
- injection frequency
- timing
- procedural technique
This makes comparing studies difficult.
One PRP protocol may not be equivalent to another.
How PRP Differs From Steroid Or Hyaluronic Acid Injections
Patients often ask:
“Which one is best?”
This is not a simple universal answer.
Broadly:
Steroids:
- anti-inflammatory emphasis
- commonly considered for flares/swelling
Hyaluronic acid:
- joint fluid property rationale
PRP:
- biological signalling rationale
But real-world decisions depend heavily on:
- diagnosis
- goals
- expectations
- evidence interpretation
- cost considerations
Who Might PRP Be Discussed With?
PRP may arise in discussions involving:
- non-surgical pathway exploration
- persistent symptoms
- interest in biologically oriented interventions
- situations where other options are less attractive
This does not mean every patient is suitable.
What PRP Does NOT Do
PRP does not automatically:
- cure osteoarthritis
- rebuild cartilage predictably
- eliminate surgery need
- guarantee symptom relief
- replace diagnostic clarity
- make rehabilitation unnecessary
These misconceptions create unrealistic expectations.
Cost And Practical Reality
Patients often ask:
“If PRP sounds promising, why isn’t everyone doing it?”
Practical reasons may include:
- evidence uncertainty
- cost
- protocol variability
- patient suitability
- mixed guideline positions
- differing clinician views
Shared decision-making matters.
Common Misunderstandings
“PRP regrows cartilage.”
Current evidence does not support simplistic predictable cartilage-regrowth claims in established OA.
“PRP is definitely better than steroids.”
Not automatically.
Different interventions serve different roles.
“PRP is proven for everyone.”
No.
Response varies.
Evidence remains heterogeneous.
“PRP means surgery can always be avoided.”
No.
Treatment pathways remain individualised.
What This Means For Patients
Useful practical questions include:
- What diagnosis are we treating?
- What is the realistic goal?
- Is symptom relief the objective?
- What does the evidence actually support?
- How strong is the evidence?
- What alternatives exist?
The better question is:
“Does PRP meaningfully fit my clinical situation and treatment goals?”
Practical Decision-Making Considerations
Considerations may include:
- diagnosis confidence
- osteoarthritis severity
- symptom goals
- alternative options
- patient expectations
- cost sensitivity
- broader management plan
- evidence interpretation
The American College of Rheumatology has generally remained cautious about routine recommendation, reflecting uncertainty in evidence consistency.
Based on over 20 years of clinical practice, Dr Terence Tan, founder of The Pain Relief Clinic Singapore, notes that patients often arrive expecting PRP to function like a structural joint rebuild, when the more clinically relevant discussion is whether expectations match what current evidence reasonably supports.
When Further Assessment May Matter
Further review may be particularly important when:
- diagnosis remains uncertain
- symptoms do not clearly fit osteoarthritis
- multiple overlapping causes exist
- structural clarification is needed
- expectations appear unrealistic
- prior treatment decisions have been assumption-based
Frequently Asked Questions
Does PRP regrow cartilage?
Current evidence does not support predictable structural cartilage regeneration claims in established OA.
Is PRP proven?
Evidence exists, but interpretation remains mixed.
Is PRP better than steroid injections?
Not automatically.
They serve different intended roles.
Is PRP safe?
Suitability depends on individual clinical context.
Does PRP replace surgery?
Not automatically.
Management remains individualised.
Why is evidence inconsistent?
Because protocols, study designs, and patient populations vary.
Should every arthritis patient consider PRP?
No.
It is not a universal default option.
About the contributor
Dr Terence Tan is a Singapore licensed medical doctor with over 20 years of clinical practice and founder of The Pain Relief Clinic Singapore (https://painrelief.com.sg).
Medical Disclaimer
This article is for educational purposes only and does not constitute personalised medical advice, diagnosis, or treatment recommendations. Individual medical decisions should be made in consultation with an appropriately licensed healthcare professional.
